Enzymatica Interim report Q1/2024: MDR certification opens up great commercial opportunities

/PRNewswire/ -- First quarter Net sales reached SEK 9.4 (13.0) million. The operating result totaled SEK -18.4 (-14.4) million. Earnings per share, basic and...

Related Keywords

United Kingdom ,Sweden ,Geneva ,Genè ,Switzerland ,British ,Swedish ,Stefan Olsson ,Claus Egstrand ,Assessment Of Social Services ,University Of Kent ,Enzymatica Certified Adviser Is Carnegie Investment Bank ,Global Health Summit In Geneva ,Swedish Agency For Health Technology Assessment ,Global Health Campaign ,Device Directive ,Professor Glen ,World Conference ,British Journal ,Sports Medicine ,Global Health Summit ,Swedish Agency ,Health Technology Assessment ,Social Services ,Chief Executive Officer ,Communication Manager ,Nasdaq First North Growth ,Certified Adviser ,Carnegie Investment Bank ,